Monday 15 December 2014

ASH: New Myeloma Regimens, AL Amyloidosis (CME/CE)

(MedPage Today) -- Add-on therapy with HDAC inhibitor improved outcomes in myeloma. via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)